Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma. [electronic resource]
Producer: 20120823Description: 596-602 p. digitalISSN:- 1029-2403
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation -- methods
- Hodgkin Disease -- drug therapy
- Humans
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multivariate Analysis
- Recurrence
- Retrospective Studies
- Salvage Therapy
- Transplantation, Autologous
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.